Top news of the week: 18.02.2020.
#PancreaticCancer #CRISPR #MedTech #patients #DigitalHealth #LifeSciences #biotech
Startups
RT @MassBio: #PancreaticCancer is difficult to treat with 5-year survival rates of 10%. But, new research shows the virus that causes foot-and-mouth disease in cows could hold the key for future treatments. More: https://t.co/aVzJt7kNae @FierceBiotech
OpenAttacking pancreatic cancer with the help of the virus that causes foot-and-mouth disease in cows
Pancreatic cancer remains difficult to treat, with a five-year survival rate of around 10%. While looking for ways to tackle the deadly tumor, scientists at Queen Mary University of London, ...
A super article on CIC just came out in Inc Magazine. It's so nice when a journalist seems to get what you are doing and conveys it well. https://t.co/z9nbREqZKf
OpenMoney, Ideas, and Talent Are Key Resources for Entrepreneurs. How This Innovation Hub Is Unlocking Them
The most prominent startup communities across the U.S. tend to also play host to Cambridge Innovation Center and its popular Venture Cafes.
Drug makers may be avoiding coronavirus vaccine because they've been burned before, gov't official says. https://t.co/PDhziFysi5
OpenMajor drug makers haven’t stepped up to manufacture NIH coronavirus vaccine, top U.S. health official says
The comments by the director of the National Institute of Allergy and Infectious Diseases highlight how challenging it could be to translate the NIH’s work.
#CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 https://t.co/U9IWzf7B7q https://t.co/YGdkgCijzf
OpenCRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
CRISPR, capacity, and consolidation powered the cell and gene therapy space in 2019, but a proactive focus on patient access topped Falcon Therapeutics
As the #LifeSciences continues to embrace innovation & #DigitalHealth, #MedTech will rise in prominence alongside #biotech innovation & improve access, safety & outcomes for #patients. More from Jonathan Gertler of Back Bay Life Sciences Advisors: https://t.co/k44pP22cNf
OpenWhy medtech is a different beast than biotech in the life sciences pack
Medtech innovation generally happens out of the limelight yet has an enormous impact on public health and offers significant investment opportunities.
Why Scientists Ought to Get Involved in this Election Year. By new TR contributor Jessica Sagers. (Free, shareable). https://t.co/J1JWp5W57S
OpenAs Scientists, It’s Our Duty to Speak Up as the 2020 Election Nears
As a cellular biologist deciding between staying in academia and taking a job in biotech, I was conditioned to ignore anything that sounded like “a problem for businesspeople.” I grew the ...
RT @deborah_solomon: The Trump administration wants to prevent US technology from getting to China. That’s a very big problem for a global industry. https://t.co/jX1VY7bJlu
OpenTrump Effort to Keep U.S. Tech Out of China Alarms American Firms
The administration wants to protect national security by restricting the flow of technology to China. But technology companies worry it could undermine them instead.
Priscilla Chan charts an ambitious, unglamorous course to fight disease. Zuck's involved, too.
by the inimitable @RebeccaDRobbins.
https://t.co/oTrLW3AoJv
OpenPriscilla Chan charts an ambitious, unglamorous course to fight disease. (Her husband is involved, too.)
The pediatrician and philanthropist insists the goal the couple has set — to “cure, prevent, or manage all diseases” by the year 2100 — is a realistic one.